SMLR — Semler Scientific Cashflow Statement
0.000.00%
Last trade - 00:00- $243.06m
- $180.31m
- $68.18m
- 99
- 68
- 20
- 66
Annual cashflow statement for Semler Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 15.1 | 14 | 17.2 | 14.3 | 20.6 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.619 | 0.125 | 2.38 | 1.23 | 4.55 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.894 | -1.73 | -4.58 | 1.67 | -3.74 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 12.7 | 15.1 | 16.1 | 17.5 | 21.3 |
| Capital Expenditures | -1.7 | -0.758 | -0.825 | -2.16 | -0.828 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -0.248 | 0 | -24.7 | 19.2 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.7 | -1.01 | -0.825 | -26.8 | 18.4 |
| Financing Cash Flow Items | — | 0 | -0.045 | -0.114 | -3.51 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -6.57 | 0.23 | 0.013 | -4.94 | -5.41 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.46 | 14.3 | 15.2 | -14.3 | 34.3 |